宁波美诺华药业股份有限公司关于2021年股票期权与限制性股票激励计划预留授予第二个行权期自主行权结果暨股份变动公告

Core Viewpoint - The announcement details the results of the second exercise period of the stock option and restricted stock incentive plan for Ningbo Meinuo Pharmaceutical Co., Ltd., highlighting the number of shares exercised and the timeline for trading [2][19]. Group 1: Stock Option Exercise Details - The number of shares available for exercise in the second exercise period is 738,491 shares, with the exercise period running from December 25, 2024, to November 24, 2025 [2][19]. - As of November 24, 2025, a total of 278,530 shares have been exercised, representing 37.72% of the total shares available for this exercise period [2][19]. - The shares obtained through this exercise will be credited to the stock accounts of the incentive participants on the first trading day after the exercise date (T+1) and will be listed for trading on the second trading day (T+2) [2][19]. Group 2: Decision-Making Process and Information Disclosure - On November 18, 2021, the company held its fourth board meeting, where several resolutions regarding the stock option and restricted stock incentive plan were approved, with independent directors providing their consent [3][4]. - The company convened a temporary shareholders' meeting on December 6, 2021, where over two-thirds of the voting rights approved the resolutions related to the incentive plan [5]. - Subsequent meetings in 2022 and 2023 involved adjustments to the stock option plan, including changes to the number and price of stock options and the performance indicators for the incentive plan [6][9][10]. Group 3: Impact on Financials and Share Structure - The total number of shares transferred under the incentive plan as of the announcement date is 278,530 shares, raising funds of 6,328,201.60 yuan [22]. - The exercise of these options is not expected to have a significant impact on the company's financial condition or operating results [23]. - The company's actual controlling shareholder has not changed following the exercise of these options [21].